S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea · Delayed Price · Currency is KRW 21,500
-400 (-1.83%)
At close: Sep 9, 2026
S.Biomedics Market Cap
S.Biomedics has a market cap or net worth of 266.28 billion as of September 9, 2026. Its market cap has increased by 7.94% in one year.
Market Cap
266.28B
Enterprise Value
246.53B
Revenue
16.49B
Ranking
n/a
PE Ratio
n/a
Stock Price
21,500.00
ChartMarket Cap Chart
Since May 4, 2023, S.Biomedics's market cap has increased from 206.56B to 266.28B, an increase of 28.91%. That is a compound annual growth rate of 7.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 266.28B | -41.28% |
| Dec 30, 2025 | 453.47B | 123.16% |
| Dec 30, 2024 | 203.20B | 55.86% |
| Dec 28, 2023 | 130.38B | -36.88% |
| May 4, 2023 | 206.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curocell | 366.21B |
| Inventage Lab | 356.65B |
| HansBiomed | 279.95B |
| IntoCell | 274.30B |
| IMBiologics | 215.40B |
| curacle co.,ltd. | 214.11B |
| Kangstem Biotech | 213.03B |
| Kanaph Therapeutics | 207.49B |